IVSonance provides a touchless acoustic platform that uses precisely controlled sound waves to manipulate individual cells in IVF labs, eliminating the need for micromanipulation tools.
Funding
Funding not disclosed
Founders
Product
Problem
In vitro fertilization (IVF) procedures require delicate manual micromanipulation steps, such as oocyte denudation, which are time‑consuming, operator‑dependent, and can introduce variability that affects cell integrity and outcomes.
Solution
IVSonance offers a touchless acoustic platform that uses precisely controlled sound waves to manipulate individual cells without physical contact. The system automates delicate steps like oocyte denudation, reducing handling time and minimizing operator‑induced variability. By positioning cells acoustically, the platform protects cell membranes and maintains viability while delivering faster, more consistent processing. The standalone Selective Ova Ultrasound Denudation Module (SOUND) integrates this technology into a scalable device suitable for routine use in IVF clinics. Future extensions aim to apply the same contact‑free approach to procedures such as intracytoplasmic sperm injection and cryopreservation.
Target Audience
Primary customers are IVF laboratories and embryology teams seeking to improve efficiency, consistency, and safety of delicate cell‑handling steps.
Features
- Contact‑free acoustic cell handling eliminates the need for micromanipulation tools
- Precise ultrasound‑driven positioning of oocytes for rapid denudation
- Automated workflow reduces manual handling time compared with traditional techniques
- Engineered consistency lowers variability across operators and clinics
- Gentle acoustic forces protect cell integrity during manipulation
- Standalone device design enables easy integration into existing IVF laboratory setups
- Platform architecture supports expansion to additional IVF procedures (e.g., ICSI, cryopreservation)